연구동향 분석

Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma

주이진 하성환 김병혁 김규보 지의규 장진영 김선회 한세원 임석아 김태유 방영주 오도연 2015년

논문상세정보
인용/피인용
' Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • adjuvant chemoradiotherapy
  • pancreatectomy
  • pancreatic neoplasms
  • splenic artery
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,390 0

0.0%

' Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma' 의 참고문헌

  • Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature
    Garcea G JOP 9 : 99 ~ 132 [2008]
  • Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature
    Garcea G JOP 9 99-132 [2008]
  • Splenic artery invasion in pancreatic adenocarcinoma of the body and tail : a novel prognostic parameter for patient selection
    Partelli S Ann Surg Oncol 18 : 3608 ~ 3614 [2011]
  • Splenic artery invasion in pancreatic adenocarcinoma of the body and tail : a novel prognostic parameter for patient selection
    Partelli S Ann Surg Oncol 18 3608-3614 [2011]
  • Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma
    Hattangadi JA Cancer 115 : 3640 ~ 3650 [2009]
  • Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma
    Hattangadi JA Cancer 115 3640-3650 [2009]
  • Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail
    Shimada K Surgery 139 : 288 ~ 295 [2006]
  • Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail
    Shimada K Surgery 139 288-295 [2006]
  • Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
    Van den Broeck A Eur J Surg Oncol 35 : 600 ~ 604 [2009]
  • Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
    Van den Broeck A Eur J Surg Oncol 35 600-604 [2009]
  • Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection
    Kalser MH Arch Surg 120 : 899 ~ 903 [1985]
  • Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection
    Kalser MH Arch Surg 120 899-903 [1985]
  • Management of adenocarcinoma of the body and tail of the pancreas
    Brennan MF Ann Surg 223 : 506 ~ 511 [1996]
  • Management of adenocarcinoma of the body and tail of the pancreas
    Brennan MF Ann Surg 223 506-511 [1996]
  • Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?
    Shoup M J Gastrointest Surg 7 : 946 ~ 952 [2003]
  • Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?
    Shoup M J Gastrointest Surg 7 946-952 [2003]
  • Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas
    Kanda M Ann Surg 251 : 483 ~ 487 [2010]
  • Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas
    Kanda M Ann Surg 251 483-487 [2010]
  • Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
    Regine WF Ann Surg Oncol 18 : 1319 ~ 1326 [2011]
  • Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
    Regine WF Ann Surg Oncol 18 1319-1326 [2011]
  • Ductal adenocarcinoma of the body and tail of the pancreas
    Sperti C J Am Coll Surg 185 : 255 ~ 259 [1997]
  • Ductal adenocarcinoma of the body and tail of the pancreas
    Sperti C J Am Coll Surg 185 255-259 [1997]
  • Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas
    Christein JD J Gastrointest Surg 9 : 922 ~ 927 [2005]
  • Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas
    Christein JD J Gastrointest Surg 9 922-927 [2005]
  • Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma : the Mayo Clinic experience(1975-2005)
    Corsini MM J Clin Oncol 26 : 3511 ~ 3516 [2008]
  • Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma : the Mayo Clinic experience(1975-2005)
    Corsini MM J Clin Oncol 26 3511-3516 [2008]
  • Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region : phase III trial of the EORTC gastrointestinal tract cancer cooperative group
    Klinkenbijl JH Ann Surg 230 : 776 ~ 782 [1999]
  • Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region : phase III trial of the EORTC gastrointestinal tract cancer cooperative group
    Klinkenbijl JH Ann Surg 230 776-782 [1999]
  • Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer : a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
    Van Laethem JL J Clin Oncol 28 : 4450 ~ 4456 [2010]
  • Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer : a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
    Van Laethem JL J Clin Oncol 28 4450-4456 [2010]
  • Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer : a randomized controlled trial
    Oettle H JAMA 297 : 267 ~ 277 [2007]
  • Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer : a randomized controlled trial
    Oettle H JAMA 297 267-277 [2007]
  • Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection : a randomized controlled trial
    Neoptolemos JP JAMA 304 : 1073 ~ 1081 [2010]
  • Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection : a randomized controlled trial
    Neoptolemos JP JAMA 304 1073-1081 [2010]
  • Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer : a randomised controlled trial
    Neoptolemos JP Lancet 358 : 1576 ~ 1585 [2001]
  • Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer : a randomised controlled trial
    Neoptolemos JP Lancet 358 1576-1585 [2001]
  • Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?
    Merchant NB J Am Coll Surg 208 : 829 ~ 838 [2009]
  • Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?
    Merchant NB J Am Coll Surg 208 829-838 [2009]
  • Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas
    Redmond KJ Ann Surg Oncol 17 : 3112 ~ 3119 [2010]
  • Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas
    Redmond KJ Ann Surg Oncol 17 3112-3119 [2010]
  • Adjuvant chemoradiation for pancreatic adenocarcinoma : the Johns Hopkins Hospital-Mayo Clinic collaborative study
    Hsu CC Ann Surg Oncol 17 : 981 ~ 990 [2010]
  • Adjuvant chemoradiation for pancreatic adenocarcinoma : the Johns Hopkins Hospital-Mayo Clinic collaborative study
    Hsu CC Ann Surg Oncol 17 981-990 [2010]